Archive for
March, 2009
Tuesday, March 31st, 2009
Now that my work on the April issue is (nearly) complete, I can turn my attention to our annual DTC special report, scheduled for May. And just in time, The Nielsen Company has released its list of 2008's most-recalled pharmaceutical and vaccine ads. You may remember that list as coming ...
Posted in
DTC advertising, Sales & Marketing |
1 Comment »
Tuesday, March 24th, 2009
You may have noticed the quiet around here recently. That's because Josh and Steve and Gina and Andrew are furiously working on the April issue of Med Ad News. As the editor-in-chief, I get to pull my late nights after all the layout comes to my desk. And then I ...
Posted in
Uncategorized |
No Comments »
Wednesday, March 11th, 2009
The fallout from the Supreme Court's Wyeth v. Levine decision will be added burden not just for pharmaceutical manufacturers, but FDA as well, according to Gary Liberson and Craig Wylie in PA Consulting's Life Sciences & Healthcare practice. Pharmaceutical marketers will be burdened to meet individual State product care laws. ...
Posted in
Sales & Marketing |
No Comments »
Wednesday, March 11th, 2009
Last week, on March 2, the Pharmaceutical Research and Manufacturers of America’s newly strengthened PhRMA Guiding Principles on Direct to Consumer Advertisements about Prescription Medicines went into effect. The strengthened guidelines stress patient education in a number of ways, including suggestions that “companies should consider individually setting specific periods of ...
Posted in
Patient education, Sales & Marketing |
No Comments »
Monday, March 9th, 2009
So, Merck & Co. and Schering-Plough Corp. have formed a definitive merger agreement under which Merck and Schering-Plough will merge under the name Merck in a deal valued at $23.61 per share, or $41.1 billion. Friend of Med Ad News, Mike Luby, has kindly shared his thoughts on the proposed ...
Posted in
Pharma Business |
No Comments »
Wednesday, March 4th, 2009
With the pharmaceutical industry's effort to enshrine federal FDA pre-emption in the laws of the land taking a tumble after today's Supreme Court ruling in Wyeth v. Levine, mass torts plaintiffs attorneys everywhere are licking their lips. We asked Will Sachse, a partner in the antitrust/competition and mass torts and ...
Posted in
Legal actions |
2 Comments »
Wednesday, March 4th, 2009
The pre-emption question has been answered. But it wasn't what Wyeth or the rest of the pharma industry wanted to hear.
As part of our Agenda 2009 report in January, we reported on the U.S. Supreme Court case Wyeth v. Levine, which asked the judges to decide whether federal regulations governing ...
Posted in
Legal actions, Sales & Marketing |
1 Comment »
Wednesday, March 4th, 2009
A few months ago, the pharmaceutical research company InfoMedics released the results of a survey on patient adherence that was, to say the least, depressing for pharma marketers. Among other things, the survey found that 34%Â of respondents said they do not always fill a new prescription from their doctors, 46% ...
Posted in
Sales & Marketing |
No Comments »
Wednesday, March 4th, 2009
When you look good, you feel good. Clothes make the man. Etc. etc. It’s undeniable that the way we dress says a lot about who we are and the impressions we make. So when someone’s health has an impact on their clothing choices, it’s not hard to imagine them suffering ...
Posted in
Sales & Marketing |
No Comments »
Monday, March 2nd, 2009
The Manny Awards are getting closer and closer. In about a week, we will be opening up online voting to the participating healthcare advertising agencies. On Friday and throughout the weekend, our team was busy uploading the hundreds of creative samples submitted for consideration. This year, rather than judging a ...
Posted in
Manny Awards |
No Comments »
|
|
